Teva Pharmaceutical Industries Limited (TLV:TEVA)
9,155.00
+264.00 (2.97%)
At close: Dec 4, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.60M ILS
Profits / Employee
67.86K ILS
Market Cap
105.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
| Dec 31, 2022 | 35,125 | -854 | -2.37% |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danel (Adir Yeoshua) | 4,290 |
| Kamada | 420 |
| BrainsWay | 120 |
| Bait Bakfar | 227 |
| SofWave Medical | 126 |
| Ilex Medical | 178 |
| Novolog (Pharm-Up 1966) | 936 |
| Bonus BioGroup | 49 |
Teva Pharmaceutical Industries News
- 6 hours ago - Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue - 24/7 Wall street
- 1 day ago - Teva Pharmaceutical (TEVA) Receives Sector Outperform Rating from Scotiabank | TEVA Stock News - GuruFocus
- 1 day ago - Teva Pharmaceutical Industries Ltd at Citi Global Healthcare Conference Transcript - GuruFocus
- 2 days ago - Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 days ago - Israel Has Been Mired In Controversy During Its War With Hamas. Big Tech Investment Tells A Different Story. - Investor's Business Daily
- 3 days ago - TEVA Forecasts Significant Rise in Cash Flow by 2030 - GuruFocus
- 4 days ago - Noteworthy ETF Inflows: IEFA, SPOT, SE, TEVA - Nasdaq
- 6 days ago - 30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks - The Motley Fool